CMS Changes to Medicare Advantage and Prescription Drug Benefit Programs for Contract Year 2015

by Ropes & Gray LLP
Contact

On May 19, 2014, the Centers for Medicare & Medicaid Services (“CMS”) issued a final rule, published in the Federal Register on May 23, 2014, that sets forth changes to requirements for Medicare Advantage (“MA”) and prescription drug benefit (“Part D”) programs for contract year 2015.

After receiving approximately 7,600 responses to the proposed rule, CMS intends to address at a later date certain provisions included in the proposed rule, including proposed changes to audit and inspection requirements (see Table 3 of the final rule). However, CMS also chose not to finalize certain other provisions introduced in the proposed rule, effectively withdrawing the proposals (e.g., changes to drug categories or classes of clinical concern, the limitation on stand-alone PDP sponsors to no more than two plans per PDP region, and a formal interpretation of the non-interference provision).

The regulations are effective on July 22, 2014, with some exceptions. We summarize key provisions of the final rule below.

Direct Request of Information from First Tier, Downstream and Related Entities

  • The final rule allows CMS and its designees, including antifraud contractors and other oversight agencies, to collect records directly from any first tier, downstream, or related entity (“FDRs,” e.g., pharmacy benefit managers and pharmacies). This authority is on top of existing authority to audit, evaluate and inspect such information, and stems from a 2013 OIG report finding that the current process, through which Medicare Drug Integrity Contractors (“MEDICs”) request information from FDRs indirectly through requests to MA organizations and prescription drug plan (“PDP”) sponsors, involves delays. 
  • Except in exceptional circumstances, CMS will notify MA organizations and PDP sponsors when it makes a direct request for information from one of their FDRs. 
  • CMS will publish sub-regulatory guidance explaining when direct requests of FDRs will be appropriate.

Enrollment Requirements for the Prescribers of Part D Covered Drugs

  • Section 6405 of the Affordable Care Act requires physicians and eligible professionals who order durable medical equipment, prosthetics, orthotics and supplies (“DMEPOS”) to be enrolled in Medicare. It also allows the Secretary to extend these Medicare enrollment requirements to physicians and eligible professionals who order or certify all other categories of Medicare items or services, including covered Part D drugs. The final rule provides closer oversight of Part D prescribers by requiring their enrollment in Medicare by June 1, 2015. This addresses CMS’s concerns regarding payments for drugs ordered by prescribers who do not have authority to prescribe, which has implications for patient safety.

Required Experience in the Part D Program

  • Given the availability of a large number of organizations performing key Part D functions, CMS intends to be “more discriminating” when selecting Part D plan sponsors. As such, under the final rule, any entity seeking to contract as a Part D plan sponsor (either as a stand-alone PDP or as an MA offering Part D benefits), on its own or with one of its contracted FDRs, must have served as a Part D plan sponsor for at least one full benefit year, or have performed key Part D functions (described below) for another Part D plan sponsor for at least one full benefit year. The applicant or contracted FDR must obtain this experience during the two years preceding submission of the Part D sponsor application.
  • The key Part D functions in which a prospective sponsor must have experience include:
    1. Authorization, adjudication and processing of pharmacy claims at the point of sale;
    2. Administration and tracking of enrollees’ drug benefits in real time, including automated coordination of benefits with other payers; and
    3. Operation of an enrollee appeals and grievance process.
  • It is not, however, necessary for any one single entity to have prior experience in all three areas. The requirement applies to the Part D applicant in combination with its FDRs, if any, who have Part D experience covering these key functions. Thus, joint-ventured satisfaction of the requirements is possible.

Pharmacy Price Concessions in Negotiated Prices

  • This provision changes the manner in which pharmacy price concessions are reported to CMS. Currently, certain price concessions (such as network access fees, administrative fees, technical fees and service fees) offset sponsor or PMB operating costs, but are not included in the “negotiated price” reported to CMS. The final rule redefines “negotiated price” such that all price concessions from pharmacies are reflected in negotiated prices, except contingent price concessions that cannot reasonably be determined at the point of sale. This provision will be effective in the 2016 contract year, to allow CMS to work with industry stakeholders to develop guidance as to when the exception for contingent price concessions should be applied.

Implementing Overpayment Provisions of the ACA

  • The final rule implements Section 6402 of the Affordable Care Act (“ACA”), which, through Section 1128J(d) of the Social Security Act, requires MA organizations and Part D sponsors to report and return identified Medicare overpayments within 60 days of the date of identification. The rule states that an overpayment is “identified” when the MA organization or Part D sponsor “has determined, or should have determined through the exercise of reasonable diligence,” that the MA organization or Part D sponsor has received an overpayment. The final rule also codifies a six-year look-back period for the reporting and returning of overpayments. CMS plans to release operational guidance as to when MA organizations and Part D sponsors will be deemed to have returned an overpayment.

 

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Ropes & Gray LLP | Attorney Advertising

Written by:

Ropes & Gray LLP
Contact
more
less

Ropes & Gray LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.